LCM
ABOS icon

Laurion Capital Management’s Acumen Pharmaceuticals ABOS Stock Holding History

Laurion Capital Management’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-525,444
Closed -$1.24M – 424
2026
Q1 		$1.24M Sell
525,444
-341,602
-39% -$871K 0.05% 246
2025
Q4 		$1.83M Hold
867,046
– – 0.07% 107
2025
Q3 		$1.48M Hold
867,046
– – 0.03% 173
2025
Q2 		$1.01M Hold
867,046
– – 0.02% 208
2025
Q1 		$954K Hold
867,046
– – 0.02% 175
2024
Q4 		$1.49M Hold
867,046
– – 0.03% 194
2024
Q3 		$2.15M Sell
867,046
-311,292
-26% -$844K 0.03% 153
2024
Q2 		$2.85M Sell
1,178,338
-716,685
-38% -$2.28M 0.03% 191
2024
Q1 		$7.67M Hold
1,895,023
– – 0.07% 217
2023
Q4 		$7.28M Hold
1,895,023
– – 0.06% 216
2023
Q3 		$7.86M Buy
1,895,023
+688,475
+57% +$4.25M 0.05% 236
2023
Q2 		$5.8M Hold
1,206,548
– – 0.03% 252
2023
Q1 		$4.9M Hold
1,206,548
– – 0.03% 238
2022
Q4 		$6.52M Hold
1,206,548
– – 0.03% 253
2022
Q3 		$12.1M Hold
1,206,548
– – 0.07% 175
2022
Q2 		$5.67M Buy
1,206,548
+549,700
+84% +$2.07M 0.09% 147
2022
Q1 		$2.57M Hold
656,848
– – 0.03% 199
2021
Q4 		$4.44M Hold
656,848
– – 0.04% 205
2021
Q3 		$9.76M Buy
+656,848
New +$10.9M 0.04% 277

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $1.12B AUM 41.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Laurion Capital Management's ABOS Position: Q2 2026 in Review

Laurion Capital Management sold out of Acumen Pharmaceuticals (ABOS) in Q2 2026, closing a stake of 525,444 shares — an estimated $1.24M sold.

Laurion Capital Management first reported a position in ABOS in Q3 2021 and held it in 19 quarters. The position peaked at $12.1M in Q3 2022. 96 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

  • Laurion Capital Management reported no remaining Acumen Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Laurion Capital Management sold 525,444 Acumen Pharmaceuticals shares in Q2 2026, an estimated $1.24M.
  • Laurion Capital Management first reported a position in Acumen Pharmaceuticals in Q3 2021 and held it in 19 quarters.
  • Laurion Capital Management's Acumen Pharmaceuticals position peaked at $12.1M in Q3 2022.
  • 96 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on Laurion Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.